全文获取类型
收费全文 | 464篇 |
免费 | 52篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 18篇 |
妇产科学 | 8篇 |
基础医学 | 39篇 |
口腔科学 | 12篇 |
临床医学 | 42篇 |
内科学 | 128篇 |
皮肤病学 | 8篇 |
神经病学 | 25篇 |
特种医学 | 5篇 |
外科学 | 80篇 |
综合类 | 7篇 |
预防医学 | 62篇 |
眼科学 | 4篇 |
药学 | 33篇 |
中国医学 | 1篇 |
肿瘤学 | 23篇 |
出版年
2024年 | 2篇 |
2023年 | 18篇 |
2022年 | 16篇 |
2021年 | 33篇 |
2020年 | 10篇 |
2019年 | 22篇 |
2018年 | 23篇 |
2017年 | 12篇 |
2016年 | 23篇 |
2015年 | 25篇 |
2014年 | 28篇 |
2013年 | 29篇 |
2012年 | 30篇 |
2011年 | 33篇 |
2010年 | 15篇 |
2009年 | 12篇 |
2008年 | 23篇 |
2007年 | 18篇 |
2006年 | 18篇 |
2005年 | 19篇 |
2004年 | 13篇 |
2003年 | 14篇 |
2002年 | 18篇 |
2001年 | 11篇 |
2000年 | 10篇 |
1999年 | 8篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 5篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1986年 | 3篇 |
1981年 | 1篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1972年 | 4篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有516条查询结果,搜索用时 15 毫秒
81.
82.
Palma C Overstreet MG Guedon JM Hoiczyk E Ward C Karen KA Zavala F Ketner G 《Vaccine》2011,29(8):1683-1689
Adenovirus particles can be engineered to display exogenous peptides on their surfaces by modification of viral capsid proteins, and particles that display pathogen-derived peptides can induce protective immunity. We constructed viable recombinant adenoviruses that display B-cell epitopes from the Plasmodium falciparum circumsporozoite protein (PfCSP) in the major adenovirus capsid protein, hexon. Recombinants induced high-titer antibodies against CSP when injected intraperitoneally into mice. Serum obtained from immunized mice recognized both recombinant PfCSP protein and P. falciparum sporozoites, and neutralized P. falciparum sporozoites in vitro. Replicating adenovirus vaccines have provided economical protection against adenovirus disease for over three decades. The recombinants described here may provide a path to an affordable malaria vaccine in the developing world. 相似文献
83.
Microsphaeropsis arundinis skin and soft tissue infection in renal transplant recipients: three case reports and a review of the literature 下载免费PDF全文
S.J. Crawford S.C.‐A. Chen C. Halliday G.K. Rangan T. Gottlieb A.B. Reid 《Transplant infectious disease》2015,17(6):915-920
Microsphaeropsis arundinis, a dematiaceous mold, is emerging as a cause of skin and soft tissue infection in immunocompromised hosts. Diagnosis is challenging because of the difficulty in identifying Microsphaeropsis species morphologically and few data are available to guide optimal management. We report 3 renal transplant recipients with M. arundinis soft tissue infection, where the etiological agent was diagnosed using DNA sequencing, and who were successfully treated with prolonged courses of extended‐spectrum triazole antifungal agents. 相似文献
84.
Abdallah El Sabbagh Vishal G. Patel Omar M. Jeroudi Tesfaldet T. Michael Mohammed E. Alomar Owen Mogabgab Eric Fuh Michele Roesle Bavana V. Rangan Shuaib Abdullah Jeffrey L. Hastings Jerrold Grodin Dharam J. Kumbhani Dimitrios Alexopoulos Panayotis Fasseas Subhash Banerjee Emmanouil S. Brilakis 《International journal of cardiology》2014
Background
The efficacy and safety profile of retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. We sought to perform a weighted meta-analysis of the success and complication rates of retrograde CTO PCI.Methods
We conducted a meta-analysis of 26 studies published between 2006 and April 2013 reporting in-hospital outcomes of retrograde CTO PCI. Data on procedural success, frequency of death, emergent coronary artery bypass graft surgery (CABG), stroke, myocardial infarction (MI), perforation, tamponade, stent thrombosis, major vascular or bleeding events, contrast nephropathy, and radiation skin injury were collected.Results
A total of 26 studies with 3482 patients and 3493 target CTO lesions were included. Primary retrograde CTO PCI was attempted in 52.4%. Pooled estimates of outcomes were as follows: procedural success 83.3% [95% confidence interval (CI): 79.0% to 87.7%]; death 0.7% (95% CI: 0.5% to 1.2%); urgent CABG 0.7% (95% CI: 0.4% to 1.2%); tamponade 1.4% (95% CI: 1.0% to 2.2%); collateral perforation 6.9% (95% CI: 4.6% to 10.4%); coronary perforation 4.3% (95% CI: 1.2% to 15.4%); donor vessel dissection 2% (95% CI: 0.9% to 4.5%); stroke 0.5% (95% CI: 0.2% to 1.0%); MI 3.1% (95% CI: 0.2% to 5.0%); Q wave MI 0.6% (95% CI: 0.4% to 1.1%); vascular access complications 2% (95% CI: 0.9% to 4.5%); contrast nephropathy 1.8% (95% CI: 0.8% to 3.7%); and wire fracture and equipment entrapment 1.2% (95% CI: 0.6% to 2.5%).Conclusions
Retrograde CTO PCI is associated with high procedural success rate and acceptable risk for procedural complications. 相似文献85.
Fletcher S Cummings CG Rivas K Katt WP Hornéy C Buckner FS Chakrabarti D Sebti SM Gelb MH Van Voorhis WC Hamilton AD 《Journal of medicinal chemistry》2008,51(17):5176-5197
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the current study, we designed and synthesized a series of second generation inhibitors, wherein the core ethylenediamine scaffold was varied in order to examine both the homology model of Plasmodium falciparum PFT (PfPFT) and our predicted inhibitor binding mode. We identified several PfPFT inhibitors (PfPFTIs) that are selective for PfPFT versus the mammalian isoform of the enzyme (up to 136-fold selectivity), that inhibit the malarial enzyme with IC50 values down to 1 nM, and that block the growth of P. falciparum in infected whole cells (erythrocytes) with ED50 values down to 55 nM. The structure-activity data for these second generation, ethylenediamine-inspired PFT inhibitors were rationalized by consideration of the X-ray crystal structure of mammalian PFT and the homology model of the malarial enzyme. 相似文献
86.
87.
88.
Renu Singh Alexander Kozhich Chin Pan Francis Lee Pina Cardarelli Rangan Vangipuram Rama Iyer Punit Marathe 《Biopharmaceutics & drug disposition》2020,41(8-9):319-333
The growing fraction (GF) of tumor has been reported as one of the predictive markers of the efficacy of chemotherapeutics. Therefore, a semi-mechanistic model has been developed that describes tumor growth on the basis of cell cycle, allowing the incorporation of the GF of a tumor in pharmacokinetic/pharmacodynamic (PK/PD) modeling. Efficacy data of anti-glypican 3 (GPC3) antibody drug conjugate (ADC) in a hepatocellular carcinoma (HCC) patient derived xenograft (PDX) model was used for evaluation of this proposed model. Our model was able to describe the kinetics of growth inhibition of HCC PDX models following treatment with anti-GPC3 ADC remarkably well. The estimated tumurostatic concentrations were used in tandem with human PKs translated from cynomolgus monkey for prediction of the efficacious dose. The projected efficacious human dose of anti-GPC3 ADC was in the range 0.20–0.63 mg/kg for the Q3W dosing regimen, with a median dose of 0.50 mg/kg. This publication is the first step in evaluating the applicability of GF in PK/PD modeling of ADCs. The authors are hopeful that incorporation of GF will result in an improved translation of the preclinical efficacy of ADCs to clinical settings and thereby better prediction of the efficacious human dose. 相似文献
89.
Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014 下载免费PDF全文
90.
Emmanouil S. Brilakis MD PhD Michael Lee MD Julinda Mehilli MD Konstantinos Marmagkiolis MD Josep Rodes-Cabau MD Rajesh Sachdeva MD Anna Kotsia MD George Christopoulos MD Bavana V. Rangan BDS MPH Atif Mohammed MD Subhash Banerjee MD 《Current treatment options in cardiovascular medicine》2014,16(5):1-12